PRESS RELEASE
News
-
-
-
-
PRESS RELEASE
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
Moderna, Inc. receives positive opinion from EMA CHMP for mRESVIA mRNA-1345 vaccine for RSV in adults aged 60+. The decision from the European Commission is awaited -
PRESS RELEASE
VVV Resources Limited: Annual Report and Financial Statements for the year ended 31 December 2023
Press release by VVV Resources Limited announcing their Annual Report and Financial Statements for the year ended 31 December 2023. Details include operations and finance reviews, outlook, changes in the Board, and financial figures -
-
PRESS RELEASE
AB Science fait le point sur la demande d'autorisation de mise sur le marché conditionnelle du masitinib dans la SLA
AB Science annonce un avis négatif sur la demande de mise sur le marché du masitinib dans la SLA et prévoit un réexamen du dossier. Détails sur les raisons et les prochaines étapes -
PRESS RELEASE
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
AB Science receives negative opinion from CHMP on masitinib's conditional marketing authorization for ALS treatment but plans re-examination due to urgent patient need and safety considerations -
PRESS RELEASE
EQS-Adhoc: SPORTTOTAL AG successfully completes capital increase
SPORTTOTAL AG successfully completes capital increase, raising EUR 1,384,132.00. New shares issued to shareholders and strategic investors for business expansion and working capital. Trading on Frankfurt Stock Exchange expected in calendar week 28 of 2024 -
